Go offline with the Player FM app!
Cancer: A Metabolic Disease. Prof Seyfried (Ph.D) Gives a Hopeful and Practical Masterclass on Beating Cancer
Manage episode 423324915 series 2802032
“A rapid advance in technology with a slower catchup in biology”. That simple but profound fact is at the crux of cancer. Week after week I walk into offices with dinosaur toys for my clients. Why? Because of exactly what Professor Thomas Seyfried will explain today - urban humans are evolutionary victims of the abundance of energy available, and storing all this excess, engineered and genetically modified energy is making us sick. It’s giving us cancer. But there’s good news - we have everything we need to beat cancer today.
Thomas N. Seyfried received his Ph.D. in Genetics and Biochemistry, and is currently a professor at Boston College. He is a many time award winning professor, chair of various committees and editorial boards, and has over 150 peer-reviewed publications and is the author of the book, “Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer” (Wiley, 1st ed., 2012).
The book presents extensive research that cancer can be best defined as a mitochondrial metabolic disease rather than as a genetic disease. This new concept has implications for the development of new non-toxic cancer therapies including the ketogenic diet.
Join us as we explore:
Why Professor Seyfried believes the reasons behind the rise in cancer are not a mystery, and can be precisely pinpointed.
Why the medical and academic establishmenst are getting cancer all wrong, and despite billions of dollars spent in “the war on cancer” more people die everyday than the day before, with about 70 people per hour in the US.
The what’s and how’s everyone can do to today to give themselves the best chance of preventing cancer - there’s two huge ones!
How the lives of wolves and domestic dogs clearly demonstrate the story of cancer in the modern age.
The two pronged attack Professor Seyfried believes can successfully target any cancer.
Contact
Website: https://tomseyfried.com
Mentions:
Person - Albert Schweitzer, https://www.stress.org/stress-and-cancer
Person - Dr. Christos Chinopoulos, https://www.researchgate.net/profile/Christos-Chinopoulos
Paper - Case report: Resolution of malignant canine mast cell tumor using ketogenic metabolic therapy alone, https://www.frontiersin.org/articles/10.3389/fnut.2023.1157517/full
Follow Steve's socials:
Instagram | LinkedIn | YouTube | Facebook | Twitter | TikTok
Support the show on Patreon:
As much as we love doing it, there are costs involved and any contribution will allow us to keep going and keep finding the best guests in the world to share their health expertise with you. I’d be grateful and feel so blessed by your support: https://www.patreon.com/MadeToThriveShow
Send me a WhatsApp to +27 64 871 0308.
Disclaimer: Please see the link for our disclaimer policy for all of our content: https://madetothrive.co.za/terms-and-conditions-and-privacy-policy/
233 episodes
Manage episode 423324915 series 2802032
“A rapid advance in technology with a slower catchup in biology”. That simple but profound fact is at the crux of cancer. Week after week I walk into offices with dinosaur toys for my clients. Why? Because of exactly what Professor Thomas Seyfried will explain today - urban humans are evolutionary victims of the abundance of energy available, and storing all this excess, engineered and genetically modified energy is making us sick. It’s giving us cancer. But there’s good news - we have everything we need to beat cancer today.
Thomas N. Seyfried received his Ph.D. in Genetics and Biochemistry, and is currently a professor at Boston College. He is a many time award winning professor, chair of various committees and editorial boards, and has over 150 peer-reviewed publications and is the author of the book, “Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer” (Wiley, 1st ed., 2012).
The book presents extensive research that cancer can be best defined as a mitochondrial metabolic disease rather than as a genetic disease. This new concept has implications for the development of new non-toxic cancer therapies including the ketogenic diet.
Join us as we explore:
Why Professor Seyfried believes the reasons behind the rise in cancer are not a mystery, and can be precisely pinpointed.
Why the medical and academic establishmenst are getting cancer all wrong, and despite billions of dollars spent in “the war on cancer” more people die everyday than the day before, with about 70 people per hour in the US.
The what’s and how’s everyone can do to today to give themselves the best chance of preventing cancer - there’s two huge ones!
How the lives of wolves and domestic dogs clearly demonstrate the story of cancer in the modern age.
The two pronged attack Professor Seyfried believes can successfully target any cancer.
Contact
Website: https://tomseyfried.com
Mentions:
Person - Albert Schweitzer, https://www.stress.org/stress-and-cancer
Person - Dr. Christos Chinopoulos, https://www.researchgate.net/profile/Christos-Chinopoulos
Paper - Case report: Resolution of malignant canine mast cell tumor using ketogenic metabolic therapy alone, https://www.frontiersin.org/articles/10.3389/fnut.2023.1157517/full
Follow Steve's socials:
Instagram | LinkedIn | YouTube | Facebook | Twitter | TikTok
Support the show on Patreon:
As much as we love doing it, there are costs involved and any contribution will allow us to keep going and keep finding the best guests in the world to share their health expertise with you. I’d be grateful and feel so blessed by your support: https://www.patreon.com/MadeToThriveShow
Send me a WhatsApp to +27 64 871 0308.
Disclaimer: Please see the link for our disclaimer policy for all of our content: https://madetothrive.co.za/terms-and-conditions-and-privacy-policy/
233 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.